ID 400314067 · FY 2022–2024 · 3 years
Fortress Pharmaceutical Trading — a Tbilisi-based pharmaceutical importer/trader operating from the Free Industrial Zone (Tbilisi Technology Park, O. Khizanishvili St. 264), importing finished generic medicines (e.g. amlodipine) primarily from India for the Georgian and regional markets.
curated 2026-06-25
| Line item | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|
| Total Revenue | 15,613 | 19,496 | 10,551 | -17.8% |
| Total COGS | -11,555 | -17,132 | -9,605 | -8.8% |
| Gross Profit | 4,058 | 2,364 | 946 | -51.7% |
| Gross Margin | 26.0% | 12.1% | 9.0% | |
| Total Operating Expenses | -536 | -1,574 | -130 | -50.8% |
| EBITDA | 3,522 | 790 | 817 | -51.8% |
| EBITDA Margin | 22.6% | 4.1% | 7.7% | |
| Total D&A | 0 | 0 | 0 | |
| EBIT / Operating Income | 3,522 | 790 | 817 | -51.8% |
| Total Other Income | 32 | 75 | -372 | nmf |
| Profit Before Tax | 3,554 | 865 | 445 | -64.6% |
| Total Income Tax | 0 | 0 | 0 | |
| Net Profit / (Loss) | 3,522 | 790 | 382 | -67.1% |
| Net Margin | 22.6% | 4.1% | 3.6% |
Ownership & directors from companyinfo.ge (public corporate registry).